TTOO - T2 Biosystems, Inc.

QQQ $ 474.08 $ 0.40 (0.08 %)

DIA $ 416.44 $ 2.30 (0.56 %)

SPY $ 563.62 $ 5.33 (0.95 %)

TLT $ 97.05 $ 0.00 (0 %)

GLD $ 231.30 $ -1.66 (-0.71 %)

Previous Close

$ 3.19

Open

Bid

$ 3.18 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 2.60 - $ 46.85

Volume

164,391

Average Volume

Market Cap

55.76M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-06-2024	03-31-2024	10-Q
3	04-01-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-22-2023	03-31-2023	10-Q
7	03-31-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-23-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-31-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	03-16-2020	12-31-2019	10-K
20	11-18-2019	09-30-2019	10-Q
21	08-02-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	03-14-2019	12-31-2018	10-K
24	11-01-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	03-19-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-04-2017	06-30-2017	10-Q
30	05-08-2017	03-31-2017	10-Q
31	03-15-2017	12-31-2016	10-K
32	11-08-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	03-09-2016	12-31-2015	10-K
36	11-04-2015	09-30-2015	10-Q
37	08-05-2015	06-30-2015	10-Q
38	05-06-2015	03-31-2015	10-Q
39	03-04-2015	12-31-2014	10-K
40	11-05-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

T2 Biosystems Gets Australian Approval Fo...
08/19/2024 16:16:11

https://www.tga.gov.au/resources/artg/459987

T2 Biosystems shares are trading higher af...
07/30/2024 12:01:28

Canaccord Genuity Maintains Hold on T2 Bio...
07/30/2024 11:00:22

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and raises the price target from $3 ...

T2 Biosystems Continues To Expect FY24 Tot...
07/29/2024 20:39:10

T2 Biosystems Q2 2024 GAAP EPS $(0.66) Bea...
07/29/2024 20:22:45

T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.97)...

T2 Biosystems Announces Exclusive Distribu...
07/29/2024 20:12:54

Marks Continued International Expansion Following Recent Hong Kong And Macau Entry; Aims To Improve Sepsis Care Globally, Says ...

T2 Biosystems Announces Commercial Expansi...
06/25/2024 13:16:17

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, ...

T2 Biosystems Regains Compliance With Nasdaq
05/22/2024 13:13:50

T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and anti...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
05/16/2024 16:31:11

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
05/15/2024 16:31:58

T2 Biosystems Announced $8M Private Placem...
05/15/2024 11:07:05

T2 Biosystems Announces LOI For Partnershi...
05/07/2024 13:02:31

why-zeta-global-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket

Why Zeta Global Shares Are Trading Higher ...
05/07/2024 12:11:43

T2 Biosystems shares are trading higher af...
05/07/2024 10:53:25

T2 Biosystems Reiterates Guidance
05/06/2024 20:49:18

Reiterated 2024 Financial OutlookThe Company continues to expect full year 2024 total sepsis product revenue of $10.0 million t...

T2 Biosystems Q1 2024 GAAP EPS $(2.66) Mis...
05/06/2024 20:43:54

T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(2.66) per share which missed the analyst consensus estimate of $(2.2...

T2 Biosystems Announced Execution Of Terri...
05/06/2024 20:40:41

Ttoo T2 Biosystems Files For Offering Of U...
05/06/2024 12:02:52

Canaccord Genuity Maintains Hold on T2 Bio...
04/29/2024 14:42:40

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and lowers the price target from $12...

T2 Biosystems Receives Notice Of Allowance...
04/25/2024 17:55:28

https://t.co/156OpGGCCy https://t.co/SCcZwLnY0d